Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin plus tamsulosin fixed-dose combination versus tamsulosin alone in men with LUTS associated with BPH
2008-001211-37Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of solifenacin and tamsulosin in benign prostatic hyperplasia (BPH) and Micturition disorder (3 arms), sponsored by Astellas Pharma. Primary endpoint: Change from baseline to endpoint in total I-PSS. Started May 2009; status: completed.
02
Drugs
solifenacintamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on 2008-001211-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001211-37.